biotech · Attention Deficit Hyperactivity Disorder · Vascular Ehlers-Danlos Syndrome · AYTU
AYTU BIOPHARMA
AYTU BIOPHARMA, INC
AYTU BIOPHARMA patent portfolio — 4 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Denver, USA
- Founded
- 2015
- Employees
- 105
- Programs
- 3
- Drugs
- 5
- Patents
- 4
AYTU BIOPHARMA patents
4 pharmaceutical patents indexed for AYTU BIOPHARMA. 0 expire within 24 months.
AYTU BIOPHARMA has 4 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 11534474
Oral compositions for bladder regulation and uses thereof
granted -
US 10184931
Methods and systems for measuring and using the oxidation-reduction potential of a biological sample
granted -
US 9410913
Methods and systems for measuring and using the oxidation-reduction potential of a biological sample
granted -
US 9360446
Methods and systems for measuring and using the oxidation-reduction potential of a biological sample
granted
Frequently asked questions
How many patents does AYTU BIOPHARMA have?
4 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do AYTU BIOPHARMA patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.